A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Dr Kaitin writes and speaks frequently on factors that contribute to the slow pace and high cost of pharmaceutical R&amp,D and the impact of efforts to speed the drug development process.

In the face of such pressure, pharmaceutical companies are ... to eliminate costly inefficiencies in the drug discovery and development process. The high risk/reward ratio for drug development ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...

a degree in the pharmaceutical sciences may be for you. Our undergraduate program focuses on the design, development and rational use of medication for the prevention and treatment of disease, as well ...

3 CDMOs offer a wide range of comprehensive services to pharmaceutical companies, some of which can include supporting formulation development, upscaling current drug processes, clinical trial ...

“Enhancing productivity in pharmaceutical R&D is fundamental as it accelerates the development of new drugs, enabling companies to innovate ... Target identification follows as another crucial R&D ...